NASDAQ:REVB

Revelation Biosciences Stock Insider Trading

etoro logo Buy REVB
*Your capital is at risk
$1.04
-0.0200 (-1.89%)
At Close: Jun 03, 2026

Revelation Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.41. In total, the insiders bought 2.36M and sold 185.54K REVB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
91.41
Buy 2.36M shares
Sell 185.54K shares
79% Buy Activity
Strong Negative Correlation
Sell Signal Low Confidence
Apr 30, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 91.41.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 90.

Historical Insider Trades

Date Type Person Role Amount
Apr 30, 2026
Sell
Common Stock
F-InKind
Rolke James
Chief Executive Officer
CEO / President 10 115
Value: $11.4K
Apr 30, 2026
Sell
Common Stock
F-InKind
Zygmont Chester Stanley Iii
Chief Financial Officer
C-Suite Officer 13 285
Value: $14.6K
Feb 04, 2026
Sell
Common Stock
F-InKind
Zygmont Chester Stanley Iii
Chief Financial Officer
C-Suite Officer 13 100
Value: $21.6K
Feb 03, 2026
Sell
Common Stock
F-InKind
Roper Jess
Director
Director 1 591
Value: $3K
Feb 03, 2026
Sell
Common Stock
F-InKind
Chawla Lakhmir S
Director
Director 2 261
Value: $4K
Feb 03, 2026
Sell
Common Stock
F-InKind
Carver Jennifer
Director
Director 1 661
Value: $3K
Feb 03, 2026
Sell
Common Stock
F-InKind
Rolke James
Chief Executive Officer
CEO / President 8 521
Value: $15.8K
Jan 08, 2026
Buy
Common Stock
A-Award
Rolke James
Chief Executive Officer
CEO / President 532 829
Value: $479.5K
Jan 08, 2026
Buy
Common Stock
A-Award
Zygmont Chester Stanley Iii
Chief Financial Officer
C-Suite Officer 78 145
Value: $70.3K
Jan 08, 2026
Buy
Common Stock
A-Award
Carver Jennifer
Director
Director 41 981
Value: $37.8K
Jan 08, 2026
Buy
Common Stock
A-Award
Roper Jess
Director
Director 41 981
Value: $37.8K
Jan 08, 2026
Buy
Common Stock
A-Award
Chawla Lakhmir S
Director
Director 41 981
Value: $37.8K
Oct 29, 2025
Buy
Common Stock
A-Award
Chawla Lakhmir S
Director
Director 15 625
Value: $20.0K
Oct 29, 2025
Buy
Common Stock
A-Award
Rolke James
Chief Executive Officer
CEO / President 390 614
Value: $500.0K
Oct 29, 2025
Buy
Common Stock
A-Award
Carver Jennifer
Director
Director 15 625
Value: $20.0K
Oct 29, 2025
Buy
Common Stock
A-Award
Zygmont Chester Stanley Iii
Chief Financial Officer
C-Suite Officer 390 614
Value: $500.0K
Oct 29, 2025
Buy
Common Stock
A-Award
Roper Jess
Director
Director 15 625
Value: $20.0K
Feb 11, 2025
Buy
Common Stock
A-Award
Chawla Lakhmir S
Director
Director 181
Value: $700
Feb 11, 2025
Buy
Common Stock
A-Award
Carver Jennifer
Director
Director 181
Value: $700
Feb 11, 2025
Buy
Common Stock
A-Award
Roper Jess
Director
Director 181
Value: $700
Feb 11, 2025
Buy
Common Stock
A-Award
Rolke James
Chief Executive Officer
CEO / President 30 095
Value: $116.5K
Feb 11, 2025
Buy
Common Stock
A-Award
Zygmont Chester Stanley Iii
Chief Financial Officer
C-Suite Officer 15 048
Value: $58.2K
Feb 11, 2025
Buy
Common Stock
A-Award
Tidmarsh George F
Director
Director 181
Value: $700
Feb 11, 2025
Buy
Common Stock
A-Award
Chawla Lakhmir S
Director
Director 181
Value: $700
Feb 11, 2025
Buy
Common Stock
A-Award
Carver Jennifer
Director
Director 181
Value: $700

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT REVELATION BIOSCIENCES, INC.
Revelation Biosciences
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is a...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE